An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Treatment-resistant Schizophrenia

Interventions

DRUG

Clozapine

We will assess inflammatory/immune marker labs

DRUG

Antipsychotics,Other (non-Clozapine)

We will assess monitor inflammatory/immune marker lab

Trial Locations (1)

RECRUITING

Ohio State University Harding Hospital, Columbus

All Listed Sponsors

lead

Ohio State University

OTHER